LYNN MATRISIAN was named the inaugural chief research officer for the Pancreatic Cancer Action Network. Matrisian was promoted from vice president of scientific and medical affairs, where she has served since 2011. Doug Laidlaw was named vice president of scientific and medical affairs, and will be responsible for overseeing the nonprofit’s research grants, patient services...
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
